Regis Kelly, PhD, OBE, Venture Partner
Prior to joining QB3 in 2004, Regis Kelly served as executive vice-chancellor at UCSF; he oversaw the UCSF research enterprise and was also responsible for construction of the new Mission Bay campus. Kelly was appointed an Officer of the Order of the British Empire (OBE) in the 2014 New Year Honours for services to science, innovation, and global health. He joined the UCSF Department of Biochemistry in 1971 and has served as director of the Cell Biology Graduate Program, director of the Hormone Research Institute, and chair of the Department of Biochemistry and Biophysics. In 2015, he was awarded the inaugural Byers Family Distinguished Professorship at UCSF. He was chairman of the Bay Area Scientific Innovation Consortium and has served on the boards of the Malaysian Biotechnology Industry Advisory Board, the Scleroderma Research Foundation, and Bridge Pharmaceuticals. He is an advisor to the Thailand Bionanotechnology Institute, Ho Chi Minh City Biotechnology Department Corp., University of Oxford Systems Biology Program, and the San Francisco Mayor’s Biotechnology Advisory Group. Kelly earned an undergraduate degree in physics from the University of Edinburgh and a PhD in biophysics from the California Institute of Technology.